Celldex Therapeutics (CLDX) Receivables (2016 - 2025)
Historic Receivables for Celldex Therapeutics (CLDX) over the last 16 years, with Q3 2025 value amounting to $90000.0.
- Celldex Therapeutics' Receivables fell 8943.66% to $90000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $90000.0, marking a year-over-year decrease of 8943.66%. This contributed to the annual value of $700000.0 for FY2024, which is 7336.38% down from last year.
- As of Q3 2025, Celldex Therapeutics' Receivables stood at $90000.0, which was down 8943.66% from $90000.0 recorded in Q2 2025.
- In the past 5 years, Celldex Therapeutics' Receivables registered a high of $2.7 million during Q1 2024, and its lowest value of $90000.0 during Q2 2025.
- In the last 5 years, Celldex Therapeutics' Receivables had a median value of $347000.0 in 2022 and averaged $783263.2.
- Its Receivables has fluctuated over the past 5 years, first soared by 120000.0% in 2024, then plummeted by 9413.3% in 2025.
- Celldex Therapeutics' Receivables (Quarter) stood at $172000.0 in 2021, then surged by 101.74% to $347000.0 in 2022, then soared by 657.35% to $2.6 million in 2023, then crashed by 73.36% to $700000.0 in 2024, then tumbled by 87.14% to $90000.0 in 2025.
- Its Receivables was $90000.0 in Q3 2025, compared to $90000.0 in Q2 2025 and $1.1 million in Q1 2025.